RITA (NSC 652287)

Alias: RITA; NSC-652287; NSC652287; NSC 652287
Cat No.:V0015 Purity: ≥98%
RITA (also known as NSC-652287) is a novel and potent inhibitor of p53-HDM-2 protein-protein interaction with potential anticancer activity.
RITA (NSC 652287) Chemical Structure CAS No.: 213261-59-7
Product category: p53
This product is for research use only, not for human use. We do not sell to patients.
Size Price Stock Qty
2mg
5mg
10mg
25mg
50mg
100mg
250mg
Other Sizes
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text

 

  • Business Relationship with 5000+ Clients Globally
  • Major Universities, Research Institutions, Biotech & Pharma
  • Citations by Top Journals: Nature, Cell, Science, etc.
Top Publications Citing lnvivochem Products
Purity & Quality Control Documentation

Purity: ≥98%

Product Description

RITA (also known as NSC-652287) RITA (also known as NSC-652287) is a brand-new and powerful protein-protein interaction inhibitor with potential anticancer activity for the p53-HDM-2 protein. It induces DNA-DNA cross-links and binds to p53dN with a Kd of 1.5 nM.

Biological Activity I Assay Protocols (From Reference)
Targets
p53dN (Kd = 1.5 nM)
ln Vitro
In tumor cell lines, RITA displays a highly selective pattern of differential cytotoxic activity as a result of cellular accumulation to the cytosolic (S100) fraction. With IC50 values of 13 M and 37 M, respectively, RITA also inhibits the growth of other renal cell lines, such as ACHN and UO-31.[1] RITA (10 nM) causes cell cycle arrest with an accumulation of cells in the G2-M phase, and at 100 nM, it causes DNA fragmentation and apoptosis with assessed p53 protein levels in both cases. In A498 cells, RITA (30 nM) also causes DNA-protein and DNA-DNA cross-links. RITA has no impact on the top1-mediated relaxation of supercoiled SV40 DNA in the interim.[2] RITA significantly (97%) inhibits the growth of HCT116 cells, but only marginally (13%), inhibits the growth of HCT116 cells that lack the TP53 gene. In comparison to cell lines lacking p53 and those expressing mutant p53, tumor cell lines expressing wild-type p53 are much more effective at growth inhibition when treated with RITA. The rescue of MDM2's embryonic lethality provides strong evidence that RITA binds full-length p53 but not GST protein or HDM-2 (a key regulator of p53). RITA prevents p53 ubiquitination and interaction with HDM-2. Despite the fact that both proteins are upregulated, RITA significantly reduces the amount of HDM-2 that co-precipitates with p53. RITA blocks interactions between 6XHis-tagged His-HDM-2 proteins and purified GST-p53. [3] RITA has been demonstrated to promote p53Ser46 phosphorylation, which causes apoptosis.[4] RITA induces activation of p53 in conjunction with up-regulation of phosphorylated ASK-1, MKK-4 and c-Jun. RITA induces the activation of JNK signaling.[5] But On the contrary, another results by nuclear magnetic resonance (NMR) show that RITA does not block the formation of the complex between p53 (residues 1-312) and the N-terminal p53-binding domain of MDM2 (residues 1-118), which is highly probable that the binding of RITA requires native conformation of p53.[6]
ln Vivo
RITA is well tolerated in mice after intraperitoneal administration, and weight loss is not noticeable at doses up to 10 mg/kg over the course of a month. The growth of the HCT116 tumors is 40% suppressed after five injections of 0.1 mg/kg RITA, with no discernible effects on the HCT116 TP53-/- tumors. RITA exhibits significant antitumor activity at doses of 1 or 10 mg/kg. The growth rate of p53-positive xenografts is reduced by more than a factor of two after five 1 mg/kg injections of RITA, while p53-null xenografts are unaffected. Compared to untreated control mice, mice given 10 mg/kg of RITA had 90% fewer HCT116 tumors. RITA slows the growth of the tumor in a way that is dependent on wild-type p53. [3]
Cell Assay
The XTT assay is used to evaluate the sensitivity of cells to RITA (0.1 nM - 1 mM). 1500 cells are seeded into each well of 96-well flat-bottom plates, which are then incubated for 24 hours at 37 °C in a humidified atmosphere of 5% CO2 and 5% air. The wells receive incremental additions of RITA dissolved in DMSO, and 48 hours later, sensitivity is assessed.
Animal Protocol
Mice: Female SCID mice, 4-6 weeks old, are implanted with subcutaneous xenografts using 1 × 106 cells in 90% Matrigel. After 3-6 days have passed since the cells were injected, palpable tumors have developed, at which point RITA treatment is started. RITA is injected intravenously or intraperitoneally once daily in doses of 0.1, 1 or 10 mg/kg in phosphate buffered saline totaling 100 L. Xenografts are assessed every two days. The average tumor volume for each data point is divided by the average starting tumor volume to plot the tumor volumes for the control and treated groups[1].
References

[1]. Biochem Pharmacol. 1999 Jun 1;57(11):1283-95.

[2]. Mol Pharmacol. 1999 Sep;56(3):478-84.

[3]. Nat Med. 2004 Dec;10(12):1321-8.

[4]. Biochem Biophys Res Commun. 2012 Jan 20;417(3):931-7.

[5]. PLoS One. 2012;7(1):e30215.

[6]. Nat Med. 2005 Nov;11(11):1135-6; author reply 1136-7.

These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C14H12O3S2
Molecular Weight
292.4
Exact Mass
292.0228
Elemental Analysis
C, 57.51; H, 4.14; O, 16.42; S, 21.93
CAS #
213261-59-7
Appearance
Solid powder
SMILES
C1=C(SC(=C1)C2=CC=C(O2)C3=CC=C(S3)CO)CO
InChi Key
KZENBFUSKMWCJF-UHFFFAOYSA-N
InChi Code
InChI=1S/C14H12O3S2/c15-7-9-1-5-13(18-9)11-3-4-12(17-11)14-6-2-10(8-16)19-14/h1-6,15-16H,7-8H2
Chemical Name
[5-[5-[5-(hydroxymethyl)thiophen-2-yl]furan-2-yl]thiophen-2-yl]methanol
Synonyms
RITA; NSC-652287; NSC652287; NSC 652287
HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
DMSO: ~58 mg/mL (~198.4 mM)
Water: <1 mg/mL (slightly soluble or insoluble)
Ethanol: ~8 mg/mL (~27.4 mM)
Solubility (In Vivo)
30%Propylene glycol, 5%Tween 80, 65% D5W: 30 mg/mL
 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 3.4200 mL 17.0999 mL 34.1997 mL
5 mM 0.6840 mL 3.4200 mL 6.8399 mL
10 mM 0.3420 mL 1.7100 mL 3.4200 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration mg/mL;

Method for preparing DMSO stock solution mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation:Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Clinical Trial Information
NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT03052036 Recruiting Other: Optimal Medical Therapy
Procedure: Coronary Angiography
NSTEMI - Non-ST Segment Elevation
MI
Newcastle-upon-Tyne Hospitals
NHS Trust
November 2016
NCT05260203 Completed Device: RITA (App) Amyloidosis
Myelodysplasia
Multiple Myeloma
Advice Pharma Group srl June 4, 2022
Biological Data
  • RITA (NSC 652287)

  • RITA (NSC 652287)
Contact Us